RIJVY, M. T. H.; ALAM, M. S.; DHAR, U.; DIP, A. H.; QUADRY, S. A.; PARVIN, H.; AKTER, S.; ASHRAFUZZAMAN, M.; ISLAM, S.; HOSSAIN, A. K. M. M. Outcome of severe to critical COVID-19 patients with tocilizumab therapy. International Journal of Advances in Medicine, [S. l.], v. 11, n. 5, p. 455–463, 2024. DOI: 10.18203/2349-3933.ijam20242308. Disponível em: https://www.ijmedicine.com/index.php/ijam/article/view/4089. Acesso em: 18 apr. 2026.